Summary of Study ST003147
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001941. The data can be accessed directly via it's Project DOI: 10.21228/M8TM76 This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
Study ID | ST003147 |
Study Title | BT-474 cells fed with [13C2] acetate and treated with 1 uM Fasnall or 1 uM GSK2194069 for 24 h |
Study Type | Intracellular metabolomics, [13C2] acetate |
Study Summary | BT-474 breast cancer cells were fed with [13C2] acetate and treated with 1 uM Fasnall or 1 uM GSK2194069 for 24 h. Cells were grown in RPMI-1640 with 10% dialyzed FBS. |
Institute | Wistar Institute |
Department | Molecular and Cellular Oncogenesis Program, Ellen and Ronald Caplan Cancer Center |
Laboratory | Schug's Lab |
Last Name | Mukha |
First Name | Dzmitry |
Address | 3601 Spruce St, Philadelphia, PA 19104, USA |
dmukha@wistar.org | |
Phone | 2154956903 |
Submit Date | 2024-03-09 |
Num Groups | 3 |
Total Subjects | 9 |
Publications | Submission Pending |
Raw Data Available | Yes |
Raw Data File Type(s) | mzXML, raw(Thermo) |
Analysis Type Detail | LC-MS |
Release Date | 2024-04-02 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Treatment:
Treatment ID: | TR003273 |
Treatment Summary: | Cells were grown in RPMI-1640 supplemented with 200 uM [13C2] acetate and treated with 1 uM Fasnall or 1 uM GSK2194069. |
Treatment Compound: | Fasnall, GSK2194069 |
Treatment Dose: | 0 - 1 uM |
Treatment Doseduration: | 24 h |
Treatment Vehicle: | DMSO |
Cell Growth Container: | 6-well plates |
Cell Media: | RPMI-1640 |
Cell Envir Cond: | 37C, 5% CO2 |
Cell Pct Confluence: | ~70% |